A Multi-Dimensional Analysis of a Novel Approach for Wireless Stimulation by Abiri, Parinaz et al.
0018-9294 (c) 2020 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission. See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/TBME.2020.2983443, IEEE
Transactions on Biomedical Engineering
 1 
  
Abstract— The elimination of integrated batteries in biomedical 
implants holds great promise for improving health outcomes in 
patients with implantable devices. However, despite extensive 
research in wireless power transfer, achieving efficient power 
transfer and effective operational range have remained a 
hindering challenge within anatomical constraints. Objective: We 
hereby demonstrate an intravascular wireless and batteryless 
microscale stimulator, designed for (1) low power dissipation via 
intermittent transmission and (2) reduced fixation mechanical 
burden via deployment to the anterior cardiac vein (ACV, ~3.8 
mm in diameter). Methods: We introduced a unique coil design 
circumferentially confined to a 3 mm diameter hollow-cylinder 
that was driven by a novel transmitter-based control architecture 
with improved power efficiency. Results: We examined wireless 
capacity using heterogenous bovine tissue, demonstrating >5 V 
stimulation threshold with up to 20 mm transmitter-receiver 
displacement and 20o of misalignment. Feasibility for human use 
was validated using Finite Element Method (FEM) simulation of 
the cardiac cycle, guided by pacer phantom-integrated Magnetic 
Resonance Images (MRI). Conclusion: This system design thus 
enabled sufficient wireless power transfer in the face of extensive 
stimulator miniaturization. Significance: Our successful feasibility 
studies demonstrated the capacity for minimally invasive 
deployment and low-risk fixation. 
 
Index Terms—wireless medical devices, wireless pacemaker, 
inductive power transfer, implantable medical devices, 
implantable cardiovascular devices 
 
I. INTRODUCTION 
MPLANTABLE stimulators, including cardiac pacemakers and 
neuromodulation devices used for spinal cord, deep brain, 
and peripheral nerve stimulation, demand the use of device 
leads for the transmission of power from the pulse generator to 
the stimulation electrodes. Despite their extensive use, 
implanted leads can result in a variety of medical 
complications. In cardiac pacemakers alone, which account for 
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over 1 million annual implants, nearly one-in-ten patients 
experience lead-associated complications [1], [2]. This is 
compounded by immune-mediated responses that render lead 
extraction life-threatening in case of complications [3]. Despite 
recent advances in implantable biomedical devices, the 
utilization of wireless power transfer is still absent as a means 
to replace device wires. This is due to anatomical constraints 
that limit sufficient power delivery. This work will focus on the 
application of wireless power transfer for stimulation of the 
heart, which presents the combined challenges of space 
limitations and rhythmic motion. 
Recent years have introduced battery-based leadless 
pacemakers to mitigate lead-based complications [4]. However, 
integrating a battery within the pacer body increases the device 
size and weight [4]–[6]. The device’s consequently large 
deployment catheter limits anatomic accessibility and increases 
radiation exposure during implantation [5], [6]. Fixation 
anchors of leadless pacers also experience repetitive myocardial 
contractile forces, predisposing the device to detachment and 
embolization in addition to increasing the risk for right 
ventricular (RV) perforation and pericardial effusion [5], [6]. 
Furthermore, in response to battery exhaustion or device 
malfunction, immune-mediated tissue adhesion and local 
fibrosis further render device extraction challenging [5], [6].  
As an alternative approach to power implantable devices, 
harvesting cardiac and lung motion or ultrasonic vibration has 
been proposed to address battery limitations [7]–[15]. While an 
appealing technology, these solutions have yet to demonstrate 
practical use due to their reliance on an endocardial anchor or 
invasive epicardial fixation as a result of device size, their 
dependency on multiple implants and incisions, or their 
inability to harvest sufficient energy for pacing [7]–[15].  
Wireless power transfer via electromagnetic induction (near-
field) has also been established as a means to achieving a 
leadless system, but with a compromise in device size while 
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aiming to maintain power transfer efficiency and meeting 
Specific Absorption Rate (SAR) limits [16]–[24]. A large 
device prevents implant feasibility within anatomical confines, 
and exceeding SAR limits results in life-threatening tissue 
heating and damage. Inductive power transfer for miniature 
stimulators in various applications have also been proposed, but 
with insufficient power capacity for long-term cardiac pacing 
while meeting transmitter size requirements [25]–[30]. Far-
field wireless pacers have also yet to demonstrate the capacity 
to meet power demands [31], [32] or independently control 
pulse rate, duration, and voltage threshold [33].  
To address the aforementioned complications and 
constraints, we demonstrated an inductively-powered, 
batteryless, intravascular pacer combined with a unique 
intermittent transmission control architecture. Our validation 
studies were performed in alignment with standard market-
released peak pacing amplitudes (5 V [6]) and average patient 
pacing thresholds (0.8 V [34]). We examined wireless capacity 
using heterogenous bovine tissue, demonstrating > 5 V output 
voltage with an electrode impedance of 1000 ohms () at a 
displacement up to 20 mm and misalignment up to 20o. Pacing 
threshold remained above the mean amplitude of 0.80 V in 
response to various combinations of displacement (up to 30) 
mm and misalignment (up to ~45o). Feasibility analyses of 
wireless capacity indicated sufficient power transfer over MRI-
guided anatomical displacements and angular variations with 
adequate safety margin to tolerate variations. These analyses 
were demonstrated at 23-fold below the SAR limits, thus 
establishing a large safety margins for both power level 
regulation and absorption limits. Overall, this work 
demonstrated the fundamental basis for an efficient wirelessly 
powered stimulation system with sufficient operational range 
for cardiac pacing with translational implications in alternative 
organ stimulations. 
II. MATERIALS & METHODS 
A. Control System Design 
We designed an inductive power transfer system in which the 
pacer pulse activity was entirely controlled by intermittent 
power input into the wireless power transmitter tank circuit. As 
such, the corresponding wireless receiver contained no internal 
control structure or charge storage unit (e.g. battery) with its 
function being solely to transfer its input power to the 
stimulating electrodes.  
Through this mechanism, the pacer would enter “idle mode” 
during the non-stimulation period and switch to “active mode” 
during stimulation. For all studies, we set the “active mode” 
length to 1 ms. This stimulation duration is considered to be in 
the upper range for an effective pulse width as a result of the 
leveling effect of the strength-duration curve [35]. At 60 beats 
per minutes (BPM), this 1 ms “active mode” would be separated 
by intervals of 999 ms in “idle mode.” Unlike continuous 
wireless power transmission, the receiver would not consume 
power during the prominent “idle mode” as there would be no 
power-consuming circuitry or function in the remote receiver 
during this period; this would effectively reduce the power 
consumption by 1000-fold.  
This reduction would be further amplified by a shorter pulse 
duration within a given time period. Thus, the power efficiency 
is often improved by > 1000-fold as pulse duration typically 
ranges between 0.2 ms to 1 ms.  
B. Coil Design  
The design of an inductive power transfer system is guided 
by the optimization of power transfer efficiency (PTE) as 
defined by Equation 1 [36]: 
𝜂 =
𝑘2𝑄1𝑄2𝐿
1 + 𝑘2𝑄1𝑄2𝐿
.
𝑄2𝐿
𝑄𝐿
 (1), 
where 𝑘 is the coupling coefficient, Q1 is the quality factor of 
the transmitter coil, Q2 is the quality factor of the receiver coil, 
𝑄2𝐿 = 𝑄2𝑄𝐿 𝑄2 + 𝑄𝐿⁄ , and 𝑄𝐿 = 𝑅𝐿𝑜𝑎𝑑 2𝜋𝑓𝐿2⁄ . 
Thus, we may increase PTE by optimizing Q and k. The 
coupling coefficient is primarily defined by the geometry of the 
coils and their relative positions, with distance and alignment 
both impacting coupling strength [37]: 
𝑘 =
𝑟1
2𝑟2
2
√𝑟1𝑟2 (√𝑟1
2 + 𝐷2)
3  cos (𝜃) 
(2), 
 
where 𝑟1 is the radius of the transmitter, 𝑟2is the radius of the 
receiver, 𝐷 is the distance between the transmitter and receiver, 
and 𝜃 is the misalignment angle. 
The quality factor is similarly impacted by geometry due to 
its dependence on inductance, with additional guiding variables 
as show in Equation 3 [38]: 
𝑄 =
2𝜋𝑓𝐿
𝑅
 (3), 
where 𝑓 is the operating frequency, L is antenna inductance, 
and R is the effective ohmic losses. 
In a system experiencing alternating current (AC), resistance 
is defined by the complex relationship developed as a result of 
the skin effect, as shown in Equations (4) and (5) [38], and 
proximity effect, which is impacted by the spacing between 
adjacent turns of a coil [39]: 
𝑅𝐴𝐶 =
𝑙
2𝜋𝑎𝜎𝛿
  (4), 
where l is wire length, a is wire radius, σ is wire conductivity, 
and δ is skin depth defined by Equation (5) [38]. 
𝛿 =
1
√𝜋𝑓𝜇𝑜𝜇𝑟𝜎
  (5), 
where µo is the permeability of air, and µr is the permeability 
of copper. 
In the case of biomedical implants, the coils must be designed 
within a space-limited environment with potential for variations 
in distance and misalignment. Optimization of PTE is thus 
guided by the environmental constraints. While both the 
coupling coefficient and quality factor appear to have minimal 
capacity for manipulation due to their primary reliance on 
geometric variables (as shown in Eq. (2) and (3)), and thus 
implant position, modifications to the standard looped coil 
design can introduce a potential mechanism for a more efficient 
inductive link. 
Thus, we aimed to demonstrate wireless cardiac pacing via 
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intravascular fixation by utilizing a novel receiver coil 
structure. We designed the receiver coil (Fig. 1A in yellow) 
based on the limitations of the Anterior Cardiac Vein (ACV), 
where the pacer would be implanted on the heart. Thus, it was 
configured to 2.8 mm in diameter and 15 mm in length with a 
hollow center to allow for passage of blood. We fabricated the 
coil with 5 elliptical turns of a 30 AWG polyurethane-insulated 
wire with spacing in between each turn such that the planar coil 
measured 7 mm (width) x 9 mm (length). The spacing was 
implemented to minimize proximity effect losses. This planar 
elliptical coil was then continued as a meandering tail with 
spacing between each turn such that the tail measured 2.8 mm 
(width) x 6 mm (length). The elliptical segment of the coil was 
then folded into a 3-dimentional half-cylindrical coil with the 
planar meandering tail. The curved design allowed for 
increased surface area of field capture while remaining within 
the confines of the vascular implant position. 
 
 
Fig.  1: Circuit and Coil Design (A) Transmitter and receiver circuit design. Highlighted in the green is the control circuitry that determines pacing rate, rhythm, 
and level of power input. Highlighted in grey is the receiver circuitry for power conversion. Highlighted in red are the transmitter and receiver coils as positioned 
in the circuit as well as their structure. (B) Anatomical position of the subcutaneous transmitter in blue and intravascular receiver in yellow, depicted on a sagittal 
section of a human MRI. 
We fabricated the transmitter coil (Fig. 1A in blue) as a 
planar coil to minimize device thickness for subcutaneous 
implantation with minimal aesthetic impact on the patient. We 
used current pacemaker pulse generator size to guide length and 
width at 40 mm x 40 mm. Thus, we fabricated the transmitter 
coil with 18 circular turns of a 23 AWG wire with an inner 
diameter of 10 mm and outer diameter of 40 mm. Due to the 
impact of the proximity effect on coil resistance, the wires were 
spaced apart at a distance equivalent to that of the wire 
diameter. 
Upon design of the coils, the tank circuit (Fig. 1A) was 
completed using Equation 6 [38]: 
𝐶𝑟𝑒𝑠 =
1
𝐿(2𝜋𝑓)2
 (6), 
where 𝐶𝑟𝑒𝑠 is the tank capacitance, 𝐿 is coil inductance, 𝑓 is the 
operating frequency. 
The properties of the inductive link are shown in Table I. 
The transmitter tank circuit was supplied through a Class E 
Power Amplifier for optimal efficiency [40]–[42] and the 
receiver tank circuit drained into a voltage doubler for AC-DC 
conversion prior to tissue stimulation via platinum-deposited 
electrodes. 
 
 
TABLE I 
TRANSMITTER & RECEIVER COIL DESIGN  
Coil Inductance Capacitance 
Receiver  130 nH 1050 pF 
Transmitter 7.15 uH 19.3 pF 
 
Implant locations for the transmitter and receiver (Fig. 1B) 
were based on three criteria: (1) minimal distance between the 
communicating components, (2) ease of deployment, (3) 
minimal impact by complications such as stenosis of the 
selected vessel. For the transmitter, this was selected as 
subcutaneously in the anterior chest, with the aim of similar 
implant technique within a surgical pocket as existing 
pacemaker pulse generators. For the receiver, this was selected 
as the anterior cardiac vein (ACV) [43] with aim of catheter-
based delivery through the coronary sinus and distal to the 
greater cardiac vein. 
C. Measurement of Wireless Power Transfer Range 
To determine the range of function for the proposed pacer, 
we placed the transmitter and receiver at varying distances apart 
and with different degrees of misalignment. The average 
distance between the two implant positions (subcutaneous for 
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the transmitter and inside the ACV for the receiver) was set to 
20 mm [44]. We thus examined wireless power transfer 
capacity at distances of 10 mm to 30 mm between the 
transmitter and receiver. Due to myocardial contractility, the 
angle between the two components also varies over the cardiac 
cycle. Thus, we measured up to 45o misalignment in four 
directions: (1) horizontal x-axis misalignment, (2) horizontal y-
axis misalignment, (3) vertical x-axis misalignment, and (4) 
vertical y-axis misalignment.  
All of the measurements were performed with a segment of 
bovine tissue that included bone, muscle, adipose, and 
connective tissue, placed between the transmitter and receiver 
(Fig. 2). We compensated for the change in distance between 
the components via the addition or removal of layers of bovine 
muscle tissue. The electrode-tissue interface impedance was 
simulated with a 1000  resistor, which is the impedance of a 
typical high-impedance pacemaker stimulation lead electrode 
[45]. We then measured the voltage across the load in the 
receiver given an instantaneous input power of 1.26 W to the 
transmitter. 
 
Fig.  2: In Vitro Experimental Setup. Photo of experimental setup for in vitro 
analysis of power transfer efficiency over various distances and misalignment 
levels. A segment of bovine tissue containing a mixture of muscle, adipose, and 
bone was placed in between the two coils to mimic the environment of the body. 
D. Simulating Pacing Function Across a Cardiac Cycle 
We analyzed 4-dimensional (3-dimensions + time) coronal 
magnetic resonance images (MRIs) of the thorax through a 
cardiac cycle to determine the relative motion between the 
implanted transmitter and receiver components. The 
transmitter, to be implanted subcutaneously anterior to the ribs 
and sternum, was simulated as an immobile object. The receiver 
position was simulated by inserting a phantom object in the 
MRI slices at the location of the ACV (Fig. 3A). We adjusted 
the size of the phantom to the nearest voxel size relative to the 
actual device size, resulting in a rectangular phantom object of 
size 4.14 x 3.60 x 21.31 mm. 
Next, we created four versions of the 3-D phantom image, 
each containing a red marking in one of the four corners on the 
larger surface (4.14 x 21.31 mm) of the phantom. These 
markers served as representative landmarks of the surface of the 
phantom that would have the greatest contact with the 
epicardium. As previously described [46], deformable image 
registration (DIR) was applied on each time point of the 4-D 
thoracic MRI to generate 3-D displacement fields that 
represented the instantaneous cardiac motion at discrete time 
points in the cardiac cycle. To simulate the moving phantom at 
any given time point, the 3-D phantom image of the previous 
time point was transformed using the 3-D displacement field 
that was calculated for the given time point. Thus, a 4-D 
phantom image was generated for each marked version of the 
original 3-D phantom to simulate its motion throughout the 
cardiac cycle. 
To spatially track the landmarks over time, we first extracted 
the red color spectrum from each marked 4-D phantom image. 
In each 3-D image of each 4-D phantom image, we determined 
the 3-D location of the landmark by calculating the weighted 
average of non-zero pixel, using the pixel intensities as the 
weights. The resulting output was four 3-D points in each time
 
Fig.  3: MRI-Phantom Study Data Processing. (A) Coronal MRI slices and corresponding “pacer” phantom placements across the three representative slices; 
(B) The location of the red landmarks was calculated by taking the average of their position to create a 2-D version of the object. The centroid and normal vector 
were then computed based on the averaged red marks that represented the four corners. 
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point representing four corners of the phantom in a single 
averaged slice (Fig. 3B). 
Next, we computed the centroid of the four points in each 
time point to trace the changing 3-D position of the phantom 
relative to the initial position. We also calculated for the normal 
vector to the four points in each time point to trace the changing 
angular alignment of the phantom relative to the initial time 
point. 
We started simulating by first modeling the transmitter and 
receiver coils in Solidworks software (outlined in red in Fig. 
1A). The transmitter was modeled with 18 circular turns of a 23 
AWG wire with spacing equivalent to the wire diameter, 
resulting in an inner diameter of 10 mm and outer diameter of 
40 mm. The receiver was modeled with 5 circular turns of a 30 
AWG wire connected to a meandering tail, all of which was 
folded into a half-cylindrical shape with a diameter of 2.8 mm 
and length of 15 mm. Next, we imported the components into 
ANSYS Maxwell simulation software and positioned them at 
an initial mean distance of 20 mm apart [44]. The position and 
angle of the receiver in each frame was adjusted based on 
computed centroid position and normal vector of the phantom 
from the MRI tracings. Using the Eddy Current solver in 
ANSYS Maxwell, we simulated the magnetic (B) field resulting 
from the 13.56 MHz alternating current in the transmitting coil 
and its impact on the receiving coil. The coils’ internal 
resistance and inductance as well as the coupling coefficient 
between the interacting components were computed by the 
solver and imported into PSPICE Electronic Circuit 
Optimization & Simulation software. We simulated the circuit 
of Fig. 1A with a 1000  load [45]. We measured the voltage 
across the load in the receiver given an instantaneous input 
power of 1.26 W to the transmitter. 
Finally, we computed SAR using the simulated E-Field in 
ANSYS Maxwell FEM software as needed for Equation (7): 
𝑆𝐴𝑅 =
𝜎𝐸2
𝜌
 
(7) 
where 𝜎 is the electrical conductivity of the tissue and 𝜌 is the 
mass density of the tissue. 
III. RESULTS 
A. Measurement of Wireless Power Transfer Range 
To determine the range of power transfer for the proposed 
pacer, we placed the transmitter and receiver at various 
distances apart with different degrees of misalignment (Fig. 
4A). Output voltage was compared against the mean pacing 
amplitude of 0.80 V [34] (dotted line at the upper boundary of 
the red zones in Fig. 4B-F) and maximum potential amplitude 
of the market-released leadless pacemaker at 5 V [6] (dotted 
line at the upper boundary of the green zones in Fig. 4B-F). To 
evaluate the potential safety margin for the proposed system, 
we defined four conservative conditions for testing the wireless 
pacer:  
 
(1) With pacing durations typically established between 0.2 ms 
to 1 ms, we elected a 1 ms pulse duration to examine the 
maximum total power consumption. This power 
consumption can be reduced up to 80% with a shorter pulse 
duration (< 1 ms). 
(2) In the setting of short intermittent pulse delivery, Specific 
Absorption Rate (SAR) can be reduced to significantly 
below the limits set by the Federal Communications 
Committee (FCC) [47]. We performed our studies using 
1.26 W of instantaneous power, equivalent to a low average 
input power of 1.26 mW as a result of the 1 ms pulse width. 
The pacer has the potential for a higher voltage amplitude at 
the stimulating electrodes by increasing this input power. 
(3) Cardiothoracic Magnetic Resonance Images (MRI) have 
demonstrated a mean distance of 20 mm between the 
location of the subcutaneous transmitter (Tx) in the anterior 
chest, and the location of the pacer (Rx) in the ACV [44]. 
The distance between the Tx and Rx was examined at 10 
mm greater than the mean anatomical displacement to assess 
safety margins. As power transfer efficiency (PTE) 
decreases exponentially over distance, a 30 mm Tx-to-Rx 
separation demonstrates the extent of the positional safety 
margin with the given parameters. 
(4) To demonstrate the effect of cardiac motion, we simulated 
Tx-to-Rx misalignment at up to two-fold the angular change 
measured throughout a cardiac cycle in our MRI-Phantom 
studies. This wide-range analysis allowed for the assessment 
of the angular safety margin available in the designed pacer. 
 
At 20 mm mean displacement and up to 20o misalignment, 
the intravascular pacer consistently achieved a pacing 
amplitude > 5 V (Fig. 4). The amplitude remained above the 
mean pacing threshold of 0.80 V in nearly all combinations of 
displacement and misalignment. At a displacement of 30 mm 
(10 mm above the mean), the pacing amplitude remained more 
than twice the mean amplitude of 0.80 V in all cases except for 
horizontal misalignments > 20o.  
Also notable is the non-linear relationship between vertical 
misalignment and voltage amplitude, where power transfer 
efficiency increases with some degrees of misalignment. This 
angular adaption is an important characteristic of the designed 
receiver coil of the pacer unit. The bending of the circular planar 
loop into the z-axis generates a diagonal capture of the magnetic 
field; thus, negating the power losses from changes in angular 
misalignment (Fig. 4G-H). This advantage supplements the 
antenna’s hollow cylindrical shape to allow for blood flow 
through the cylindrical pacer unit. 
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Fig.  4: In Vitro Experiments. (A) A schematic of the experimental configuration illustrates the transmitter and receiver position across a segment of bovine 
tissue. (B) Output voltage decreased as the displacement between the transmitter and receiver, δ, increased from 0 to 30 mm at δ  = 20 mm and δ = 30 mm. (C) 
Output voltage fluctuated in response to x-axis vertical misalignment, α, ranging from 0 to 45 degrees at δ  = 20 mm and δ = 30 mm. (D) Output voltage fluctuated 
in response to y-axis vertical misalignment, α, ranging from 0 to 45 degrees at δ  = 20 mm and δ = 30 mm. (E) Output voltage decreased in response to x-axis 
horizontal misalignment, α, ranging from 0 to 45 degrees at δ  = 20 mm and δ = 30 mm. (F) Output voltage decreased in response to y-axis horizontal misalignment, 
α, ranging from 0 to 45 degrees at δ  = 20 mm and δ = 30 mm. (G) The effect of B-field (red arrows) capture is shown with a planar circular receiver coil in the 
presence of absence of misalignment. (H) The effect of B-field (red arrows) capture is shown with a half-cylindrical receiver coil in the presence of absence of 
misalignment. (B-F) Output voltage was compared against the average pacing amplitude of 0.80 V (dotted line at the upper boundary of the red zones) and 
maximum potential pacing amplitude of the market-released leadless pacemaker at 5 V (dotted line at the upper boundary of the green zones). 
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B. Simulating Pacing Function Across a Cardiac Cycle 
A phantom pacer was integrated into thoracic MRIs at the 
position of the ACV and tracked throughout a cardiac cycle to 
determine the relative motion (position and angle) between the 
subcutaneous transmitter and pacer unit (left inset of Fig. 5A-i-
ix). In addition, the magnetic field (B) generated from the 
alternating current (AC) excitation in the transmitter coil was 
determined over nine time points in the cardiac cycle (right inset 
of Fig. 5A-i-ix). Inductive power transfer (IPT) simulations at 
the end of systole (Fig. 5A-i) and diastole (Fig. 5A-iv) 
demonstrated sufficient power transfer at the two spectra of the 
cardiac cycle. The change in pacer position compared to the 
initial time frame, which remained below 6 mm and 20o of 
misalignment, and the resulting B-field interaction between the 
pacer and its transmitter (enhanced in zoomed-in view in Fig. 
5A-x) revealed the effect of cardiac contraction-mediated 
transmitter-receiver interaction. The maximum difference in 
field potential was observed when the pacer was in the red 
region of the B-field (B = 0.0001 T) (Fig. 5A-vi), as compared 
to the green region (B = 0.00005 T) (Fig. 5A-i).  
The outcome of the B-field strength was demonstrated in 
terms of the change in power transfer efficiency (PTE) (Fig. 
5B). PTE directly affects the output voltage, which remained 
above the peak voltage capacity of 5V throughout the recorded 
cycle (Fig. 5C). The capacity to deliver short intermittent pulses 
allowed us to maintain this threshold with low power 
consumption and tissue absorption despite the low PTE ranging 
from 2.7% to 7.6%. 
Notably, SAR remained significantly below the FCC safety 
limits. The electric (E) field strength at peak coupling (Fig. 5D) 
was computed to determine maximum tissue absorption. Based 
on peak E-field strength (Fig. 5D), conductivity values, and 
density values (Fig. 5E), maximum absorption at 1.26 mW of 
input power was computed as 0.07 W/kg. This is nearly 23 
times less than the FCC safety limit of 1.6 W/kg [47]. For this 
reason, the simulations established a basis for complying with 
the SAR safety standards while maintaining the capacity to 
increase input power to the intravascular pacer in the setting of 
anatomical variations that deviate significantly from the mean 
MRI-based measurements. 
Similar to the bench experiments, small vertical 
misalignments engendered an increase in the power transfer 
efficiency and output voltage (Fig. 5B-C). Also, although 
pacing occurs only once per cycle, our simulation experiments 
established the fundamental capacity to maintain sufficient 
power transmission throughout the cardiac cycle.  
IV. DISCUSSION 
For decades, implantable electronics have paved the way for 
life-changing therapies, including artificial pacing for cardiac 
rhythm disorders and neural stimulation for movement 
disorders, gastric immobility, and bladder contraction. 
However, a fundamental design challenge for implantable 
devices is the power source and its inherent impact on device 
size. We hereby demonstrated a batteryless and wireless pacer 
that enables catheter-based intravascular deployment. In 
essence, the presented architecture works substantially similar 
to existing lead-based pacemakers with the exception of having 
a physical connection between the pulse generator and the 
pacing electrodes. While these “remote-controlled electrodes” 
are more power-consumptive than a wired system, they have 
the capacity to significantly decrease patient morbidity and 
mortality associated with lead-based devices. We reduced the 
impact on power consumption using the presented intermittent 
transmission control architecture. The 3 mm diameter wireless 
pacer was sufficiently powered for continuous pacing using 
1.26 mW of power from a 40 mm diameter transmitter while 
remaining nearly 23 times below the SAR safety limits. This 
power requirement may be fulfilled via a rechargeable battery 
with charging intervals of over 5 months or up to years, 
depending on the pacing demand [48].  
The control architecture of a wirelessly powered system is 
fundamental to its application in implantable devices. The 
control circuitry of most inductive power transfer systems is 
positioned within the stimulating unit, thus requiring 
continuous power delivery [16]–[30]. Two approaches have 
been sought to address this architecture: (1) direct wireless 
power transfer or (2) battery-based power delivery. The former 
entails direct wireless power transfer to be sufficiently high to 
satisfy both the internal control circuit and tissue stimulation. 
Therefore, this system requires significant power delivery in the 
setting of weak coupling between the transmitter and a small-
scale receiver, resulting in tissue heating over multi-centimeter 
ranges. The latter addresses the limitations of direct wireless 
power at the expense of an integrated battery and, consequently, 
device size. Thus, currently available inductive power transfer 
systems demand sacrifice in either size or efficiency.  
In our intravascular pacer, we embedded the control circuity 
for pulse modulation within the transmitter; thus, the solution 
to size and inefficiency were not forced into mutual exclusivity. 
Using the transmitter as the primary controller, we 
compartmentalized the function of the receiver to only a 
transformation unit that is activated solely during the short 
period of stimulation. Hence, eliminating the battery mitigated 
the size issue, and transmitting intermittent wireless pulses 
compensated for power transfer inefficiency. 
Notably, intermittent power delivery allowed for reduced 
receiver size by tolerating a more weakly-coupled system while 
supplying sufficient power for stimulation. The tolerance for 
amplifying wireless power transmission is prominently 
constrained by SAR limits, which is in turn dependent on the 
duration of power transfer. Thus, instantaneous power delivery 
could be amplified by providing short-length pulses rather than 
continuous transmissions. The coupling coefficient (𝑘) is 
impacted by the distance between the interacting coils and their 
geometry as defined by Equation (2). A system that tolerates 
weak coupling thus allows for a small receiver coil (𝑑2) with a 
large distance (𝐷) between the transmitter and receiver, 
rendering our control architecture optimal for biomedical 
implants which face anatomical constraints and variations. In 
this context, the anatomic constraint of a coronary vein in the 
anterior cardiac wall warranted a receiver coil design with < 3 
mm diameter. As elucidated in our simulation and bench  
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Fig.  5: Cardiac Cycle Simulation Experiments. (A) Each box represents one timeframe in the cardiac cycle in (i)-(ix). Cardiac contraction and consequential 
pacer positional and angular motion are shown in the schematic on the left inset. Stimulation of the interaction between the transmitter and receiver coil is 
demonstrated by the magnetic field shown on the right inset. (x) demonstrates a zoomed-in view of the events in box (ix). (B) Computed power transfer efficiency 
(PTE) over the nine captured frames of the cardiac cycle. (C) Computed maximum potential voltage threshold over the nine captured frames of the cardiac cycle 
given an average input power of 1.26 mW. (D) Electric field simulation of Frame 5 of the cardiac cycle at which time point maximum coupling was observed. (E) 
Various tissue conductivities and densities, which, in combination with the Electric field, determine SAR. 
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experiments, the resulting power transfer efficiency was 
measured to be below 10% in response to a combination of 
displacements and misalignments. Nonetheless, sufficient 
power for pacing was established while remaining below the 
SAR limits. This outcome enables further increases in power 
delivery from the transmitter in the potential setting of 
additional anatomical constraints and motion. Furthermore, 
while epicardial pacing has been previously demonstrated to 
have similar thresholds as endocardial pacing [49]–[51], the 
flexibility for increased power transmission can compensate for 
any potential variations in pacing conduction and total 
activation time in epicardial pacing. 
 Finally, while the current pacer form-factor utilizes inflexible 
coils, future work will establish the fabrication of a flexible 
device to allow for intravascular delivery distal to the coronary 
sinus with the capacity to navigate the tortuous vasculature. 
This flexible device can be made possible by employing a 
biocompatible parylene-C substrate for printed coils and by 
scaling down the supporting circuitry using integrate chip (IC) 
technology [52], [53].  
V. CONCLUSION 
This work presents the groundwork for extensive device 
miniaturization using a unique control system architecture and 
coil design with the capacity for low power consumption in the 
setting of inherent efficiency and absorption limitations. This 
can be valuable for the practical utilization of inductive power 
transfer in the application of medical devices, in which 
anatomical constrains hinder operational capacity. While there 
remain challenges with regards to flexible device 
microfabrication and intravascular delivery strategy, the 
fundamental work here provides a basis for encouraging 
outcomes. Our successful studies thus inspire a promise for a 
wireless stimulator with an intravascular deployment strategy, 
with translational indications for eliminating complications 
associated with device leads, repeated surgeries for battery 
replacement, and mechanically-burdened fixation failure 
points. 
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